Abaxis Launches Quantitative Canine Lyme Disease Test

Posted: Tuesday, Dec. 27, 2011, 4:20 p.m. EST



Published:

Abaxis Inc. added a quantitative antibody test for canine Lyme disease to its line of tests available through the Abaxis Veterinary Reference Laboratories Division in Olathe, Kan., the company reported today.

The test measures a combination of antibodies to peptides which mimic certain antigens of the Borrelia burgdorferi spirochete. The antibodies are not found in vaccinated or noninfected patients, allowing for a definitive diagnosis of the disease, according to Kenneth Aron, Ph.D., Abaxis' chief technology officer.

The test may be used as a standalone diagnostic test to determine infection status or efficacy during treatment. It also may be used as a quantitative confirmation test for Abaxis’ upcoming VetScan Lyme Rapid Test, which is under development, according to the Union City, Calif.-based company.

<HOME>

Archive »Read More

Texas Now Free of VS, But Not Colorado

For the first time since May, Texas has no active cases of vesicular stomatitis, but Colorado authorities are still dealing with the disease.

Kansas State Boldly Goes in New Direction

Dr. Raymond Rowland and his Kansas State research team are collaborating with Lawrence Livermore National Laboratory to improve diagnostic tools for infectious diseases.

Grants Given to Fight Canine Epilepsy, Hypothyroidism

Research into epilepsy and hypothyroidism gets significant funding from the AKC Canine Health Foundation.

Add your comment:

Events


Show More...